Cellectar Biosciences INC NEW
Symbol: CLRB (NASDAQ)
5.28
▲ (5.68%) 0.284
Company Description:
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Key Stats
- Today's Open: $4.82
- Today's High: $6.237
- Today's Low: $4.875
- Today's Volume: 206.97K
- Yesterday Close: $5
- Yesterday High: $5.34
- Yesterday Low: $4.92
- Yesterday Volume: 79.25K
- Last Min Volume: 129
- Last Min High: $5.284
- Last Min Low: $5.177
- Last Min VWAP: $5.177
Company Profile
- Name: Cellectar Biosciences INC NEW
- Website: https://www.cellectar.com
- Listed Date: 2005-04-19
- Location: FLORHAM PARK, NJ
- Market Status: Active
- CIK Number: 0001279704
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $15.96M
- Round Lot: 100
- Outstanding Shares: 3.19M
- Asset Type: CS
RECENT FILINGS FOR CLRB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-08 | SCHEDULE 13G | View |
| 2025-07-08 | SCHEDULE 13G | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-02 | 424B4 | View |
| 2025-07-01 | EFFECT | View |
| 2025-06-30 | CORRESP | View |
| 2025-06-30 | CORRESP | View |
| 2025-06-30 | S-1/A | View |
| 2025-06-26 | 8-K | View |
| 2025-06-26 | S-1 | View |
| 2025-06-25 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-13 | 8-K | View |
Latest News on CLRB